These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29934227)

  • 1. Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study.
    Ferrières J; Lautsch D; Ambegaonkar BM; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Velkovski-Rouyer M; Horack M; Almahmeed W; Chiang FT; Poh KK; Elisaf M; Brudi P; Gitt AK
    Int J Cardiol; 2018 Nov; 270():21-27. PubMed ID: 29934227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
    Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Gitt AK; Lautsch D; Ferrières J; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Ashton V; Horack M; Almahmeed W; Chiang FT; Poh KK; Brudi P; Ambegaonkar B
    Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.
    Ferrieres J; De Ferrari GM; Hermans MP; Elisaf M; Toth PP; Horack M; Brudi P; Lautsch D; Bash LD; Baxter CA; Ashton V; Ambegaonkar B; Gitt AK
    Eur J Prev Cardiol; 2018 Dec; 25(18):1966-1976. PubMed ID: 30335504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II.
    Poh KK; Chin CT; Tong KL; Tan JKB; Lim JS; Yu W; Horack M; Vyas A; Lautsch D; Ambegaonkar B; Brudi P; Gitt AK
    Singapore Med J; 2019 Sep; 60(9):454-462. PubMed ID: 30773600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study.
    Vedin O; Hagström E; Stewart R; Brown R; Krug-Gourley S; Davies R; Wallentin L; White H; Held C
    Eur J Prev Cardiol; 2013 Aug; 20(4):678-85. PubMed ID: 22496275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007-2010).
    Tang L; Patao C; Chuang J; Wong ND
    Am J Cardiol; 2013 Oct; 112(8):1126-32. PubMed ID: 23827404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Benefits of a Comprehensive Cardiac Rehabilitation Program for Patients with Acute Coronary Syndrome: A Follow-Up Study.
    Craciun LM; Buleu F; Pah AM; Badalica-Petrescu M; Bodea O; Man DE; Cosor OC; Iurciuc S; Dragan S; Rada M
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current discharge management of acute coronary syndromes: baseline results from a national quality improvement initiative.
    Wai A; Pulver LK; Oliver K; Thompson A
    Intern Med J; 2012 May; 42(5):e53-9. PubMed ID: 20646093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
    J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial.
    Xavier D; Gupta R; Kamath D; Sigamani A; Devereaux PJ; George N; Joshi R; Pogue J; Pais P; Yusuf S
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):244-253. PubMed ID: 26857999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.
    Gunnell AS; Hung J; Knuiman MW; Nedkoff L; Gillies M; Geelhoed E; Hobbs MS; Katzenellenbogen JM; Rankin JM; Ortiz M; Briffa TG; Sanfilippo FM
    Cardiovasc Ther; 2016 Dec; 34(6):423-430. PubMed ID: 27489053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of acute coronary syndromes in Maghreb countries: The ACCESS (ACute Coronary Events - a multinational Survey of current management Strategies) registry.
    Moustaghfir A; Haddak M; Mechmeche R
    Arch Cardiovasc Dis; 2012 Nov; 105(11):566-77. PubMed ID: 23177485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.